Cancer incidence and mortality in France in 1975-95
Cancer incidence and mortality in France in 1975-95
复制标题
DOI：
10.1097/00008469-199710000-00005
复制
发表时间：
1997-01-01
影响因子：
2.4
通讯作者：
Schaffer, P
中科院分区：
文献类型：
--
作者：
Menegoz, F;Black, RJ;Schaffer, P
欧洲癌症登记网络（ENCR）的目标是提高欧洲癌症登记数据的质量、可比性和可用性。这份关于法国癌症发病率和死亡率的文件提供了现有的最新数据，并附有到1995年的短期预测，以及在可能的情况下根据法国进行的流行病学研究作出的评论。在1975年至1995年的整个研究期间，法国男性癌症发病率有所增加，从1975年的92，000例新发病例增加到1995年的约135，000例。这一增长的部分原因是法国人口老龄化，但发病率也有所上升，特别是从1975年至1985年。这一趋势在1990年代似乎趋于平稳，1995年的发病率约为每100，000人482人（这一比率和随后的比率按欧洲标准人口标准化）。在女性中，20世纪70年代和80年代的所有癌症发病率也有所上升。虽然增长率不如男子明显，但这一趋势在1990年代仍在继续。1995年的估计年龄标准化比率为每100 000人309人，即104 000个新病例。在过去十年中，这些变化的主要组成部分是男性大肠癌和前列腺癌的增加，口腔癌、喉癌和胃癌的减少部分抵消了这一增加。对妇女来说，这一趋势主要是乳腺癌的持续增加，大肠癌和肺癌也在增加。在妇女患的癌症中，只有胃癌有明显的下降。1995年的情况是，乳腺癌仍然是影响法国妇女的主要癌症，几乎占所有新诊断癌症病例的三分之一，占癌症死亡人数的五分之一。其次是女性最常见的癌症是大肠癌。令人遗憾的是，妇女的乳腺癌和肠癌发病率都在增加。1995年法国男子最常见的癌症是前列腺癌、大肠癌和肺癌，所有这些癌症的发病率自1975年以来都有所增加。虽然估计1995年新诊断出的前列腺癌病例将多于肺癌，但肺癌将造成更多的死亡，特别是青年男子的死亡。
The aims of the European Network of Cancer Registries (ENCR) are to improve the quality, comparability and availability of cancer registry data in Europe. This paper on cancer incidence and mortality in France presents the most recent available data, with short-term projections to 1995, and a commentary based, where possible, on epidemiological research carried out in France. Cancer incidence in men in France increased throughout the study period 1975 to 1995, from 92,000 new cases in 1975 to about 135,000 in 1995. This increase was partly due to the ageing of the French population, but incidence rates have also increased, particularly from 1975 to 1985. The trend appears to be levelling off in the 1990s, with an incidence rate in 1995 of about 482 per 100,000 (this and subsequent rates quoted are standardized to the European Standard Population). Among women, the all-cancer incidence rates also increased during the 1970s and 1980s. Although the rate of increase was less pronounced than in men, the trend is continuing in the 1990s. The estimated age standardized rate in 1995 was 309 per 100,000, representing 104,000 new cases. The main components of these changes in the last decade were, for men, increases in large bowel and prostate cancer, which have been partly compensated for by decreases in oral cavity, larynx and stomach cancer. For women the trend was dominated by the continuing increase in breast cancer with increases also in large bowel and lung cancers. Of the numerically important cancers in women, only stomach cancer has shown a clear decline. The situation in 1995 was that breast cancer remained the predominant cancer affecting women in France, accounting for almost one third of all new cases of cancer diagnosed and one fifth of cancer deaths. The next most frequent cancers in women were those of the large bowel. Regrettably, incidence rates of both breast and bowel cancer are increasing in women. For men in France the most frequent cancers in 1995 were those of the prostate, large bowel and lung, all of which increased in incidence since 1975. Although it is estimated that there will be more newly diagnosed cases of prostate cancer than lung cancer in 1995, the latter will cause many more deaths, particularly of young men.